NCT00171548View on ClinicalTrials.gov

Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients

CompletedOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2007

Conditions

Metabolic Syndrome

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY